Headache is frequently listed among the symptoms reported by women with macromastia. Yet for decades, it has often been labeled as “tension-type” without formal diagnostic classification. A recent study published in Cephalalgia Reports suggests that assumption may be incorrect.
In this blog, we break down what the data show, why it matters clinically, and how it may change the way we evaluate women with macromastia and recurrent headache.
Title: Understanding headache in the context of macromastia: An observational pilot study of headache profiles and postoperative changes
Published: February 2, 2026
Journal: Cephalalgia Reports
DOI: 10.1177/25158163261416853
This prospective cohort study followed 34 adult women with:
Participants were evaluated before surgery, at 12 to 16 weeks postoperatively, and again 19 to 28 months after surgery.
The primary question was simple but important:
How many of these patients actually have migraine?
Using the ID Migraine screening tool and semi structured interviews aligned with the criteria of the International Headache Society, 91 percent of participants screened positive for migraine.
This directly challenges the long standing assumption in surgical literature that headache in macromastia is primarily tension type.
Even more notable:
That chronic migraine proportion is far higher than expected in general migraine populations.
This was not a mild headache cohort.
At baseline:
Only 38 percent had previously been evaluated by a neurologist.
For clinicians, this highlights a potential under recognition of migraine phenotype in women presenting primarily for surgical consultation.
Although 91 percent screened positive for migraine, every participant reported at least one red flag feature such as:
These findings raise concern for secondary headache disorders, particularly idiopathic intracranial hypertension in obese women of reproductive age.
Importantly, the study did not include standardized neurologic examination or mandatory neuroimaging at baseline.
This leaves an open question:
Are we seeing migraine exacerbated by macromastia, a new secondary headache entity, or an underdiagnosed intracranial pressure disorder?
From a clinical perspective, red flags warrant careful evaluation before attributing symptoms to musculoskeletal strain alone.
At both short term and long term follow up, participants demonstrated statistically significant improvements in:
At long term follow up, nearly 90 percent achieved at least 50 percent reduction in headache frequency.
Improvements were sustained up to 28 months postoperatively.
Patient satisfaction with surgery was high, reaching 100 percent at long term follow up.
The mechanism remains unclear, but several hypotheses emerge.
Chronic cervical and thoracic strain may contribute to peripheral sensitization. Reduction mammoplasty decreases mechanical traction.
Baseline rates of allodynia suggest central sensitization. Reduced nociceptive input could theoretically decrease central hyperexcitability.
OSA risk scores improved postoperatively. Better sleep quality may reduce headache frequency.
Improved mood, exercise capacity, and body image may indirectly influence headache burden.
Interestingly, higher BMI was associated with greater headache response, although weight loss itself did not explain improvements.
Reduction mammoplasty does not typically produce substantial systemic weight loss, so mechanisms likely extend beyond simple BMI reduction.
When women with macromastia report frequent headaches, migraine should be actively considered.
Symptoms such as pulsatile tinnitus and Valsalva aggravated pain should prompt further evaluation.
A structured headache evaluation may:
This was a small observational pilot study. It does not establish reduction mammoplasty as a treatment for migraine.
Causality cannot be inferred.
Migraine disproportionately affects women in reproductive years. Macromastia also commonly presents in this demographic.
This overlap raises important questions:
These questions remain unanswered but are now firmly on the research agenda.
The findings are hypothesis generating, not definitive.
Headache in macromastia may not be “just tension-type.” In this cohort:
Before assuming a purely musculoskeletal etiology, consider formal headache classification and evaluation for secondary causes.
Interdisciplinary collaboration between plastic surgeons and neurologists may improve patient outcomes and diagnostic accuracy.
Pocock KS, Rigdon J, Wells RE, et al. Understanding headache in the context of macromastia: An observational pilot study of headache profiles and postoperative changes. Cephalalgia Reports. Published online February 2, 2026. doi:10.1177/25158163261416853
This blog is intended for healthcare professionals. It summarizes findings from a single observational pilot study and does not establish causality or clinical guidelines. Reduction mammoplasty should not be recommended as a primary treatment for headache based solely on these findings. Clinical decisions should be individualized and grounded in comprehensive neurologic evaluation and current evidence.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.